The effect of tranexamic acid in traumatic brain injury: A randomized controlled trial

PURPOSE: Traumatic brain injury (TBI) is a leading cause of death and disability. Intracranial hemorrhage (ICH) secondary to TBI is associated with a high risk of coagulopathy which leads to increasing risk of hemorrhage growth and higher mortality rate. Therefore, antifibrinolytic agents such as tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Jokar, Abolfazl, Ahmadi, Koorosh, Salehi, Tayyebeh, Sharif-Alhoseini, Mahdi, Rahimi-Movaghar, Vafa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5343096/
https://www.ncbi.nlm.nih.gov/pubmed/28209450
http://dx.doi.org/10.1016/j.cjtee.2016.02.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5343096/
https://www.ncbi.nlm.nih.gov/pubmed/28209450
http://dx.doi.org/10.1016/j.cjtee.2016.02.005

Ejemplares similares